Recombinant CD19 (Inebilizumab Biosimilar) 抗体
This anti-CD19 (Inebilizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting CD19 (Inebilizumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant CD19 (Inebilizumab Biosimilar) 抗体 (ABIN7488071)
抗原
CD19 (Inebilizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This CD19 (Inebilizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Inebilizumab Biosimilar - Anti-CD19 mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CD19 (Inebilizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
MEDI-551
Inebilizumab is a humanized afucosylated monoclonal IgG1 antibody that targets the broadly expressed B-cell surface antigen CD19. Inebilizumab is cytolytic, which may be usefull to treat neuromyelitis optica spectrum disorder (NMOSD)through B-cell depletion. -
CAS-编号
- 1299440-37-1
抗原
-
You are here:
